Oscar Health (NYSE:OSCR) Stock Rating Lowered by Wall Street Zen

Oscar Health (NYSE:OSCR - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Sunday.

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $16.50.

Oscar Health Trading Down 3.7%

NYSE:OSCR traded down $0.55 on Friday, hitting $14.14. 14,019,768 shares of the stock were exchanged, compared to its average volume of 4,729,891. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $3.60 billion, a price-to-earnings ratio of -706.65 and a beta of 1.73. The company's 50-day moving average price is $13.95 and its 200 day moving average price is $14.52. Oscar Health has a 52 week low of $11.20 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the prior year, the firm posted $0.62 EPS. The business's revenue was up 42.2% on a year-over-year basis. On average, equities research analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 24.39% of the company's stock.

Institutional Trading of Oscar Health

Large investors have recently bought and sold shares of the business. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in shares of Oscar Health in the first quarter worth approximately $30,000. Larson Financial Group LLC lifted its stake in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after acquiring an additional 2,512 shares during the period. CWM LLC increased its holdings in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after purchasing an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its holdings in Oscar Health by 484.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock worth $45,000 after purchasing an additional 2,854 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.